JP2009503093A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009503093A5 JP2009503093A5 JP2008525132A JP2008525132A JP2009503093A5 JP 2009503093 A5 JP2009503093 A5 JP 2009503093A5 JP 2008525132 A JP2008525132 A JP 2008525132A JP 2008525132 A JP2008525132 A JP 2008525132A JP 2009503093 A5 JP2009503093 A5 JP 2009503093A5
- Authority
- JP
- Japan
- Prior art keywords
- insulin
- composition
- patient
- dose
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70429505P | 2005-08-01 | 2005-08-01 | |
| PCT/US2006/030014 WO2007016600A2 (en) | 2005-08-01 | 2006-08-01 | Method of preserving the function of insulin-producing cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015002059A Division JP2015091854A (ja) | 2005-08-01 | 2015-01-08 | インスリン産生細胞の機能を保持する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009503093A JP2009503093A (ja) | 2009-01-29 |
| JP2009503093A5 true JP2009503093A5 (cg-RX-API-DMAC7.html) | 2009-09-03 |
Family
ID=37561086
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008525132A Pending JP2009503093A (ja) | 2005-08-01 | 2006-08-01 | インスリン産生細胞の機能を保持する方法 |
| JP2015002059A Pending JP2015091854A (ja) | 2005-08-01 | 2015-01-08 | インスリン産生細胞の機能を保持する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015002059A Pending JP2015091854A (ja) | 2005-08-01 | 2015-01-08 | インスリン産生細胞の機能を保持する方法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1915171B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2009503093A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101232899A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006275424B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0614489A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2617226A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1915171T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2439455T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008001643A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007016600A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| WO2003080149A2 (en) | 2002-03-20 | 2003-10-02 | Mannkind Corporation | Inhalation apparatus |
| EP1786784B1 (en) | 2004-08-20 | 2010-10-27 | MannKind Corporation | Catalysis of diketopiperazine synthesis |
| CN104436170B (zh) | 2004-08-23 | 2018-02-23 | 曼金德公司 | 用于药物输送的二酮哌嗪盐 |
| IN2014DN09128A (cg-RX-API-DMAC7.html) | 2005-09-14 | 2015-07-10 | Mannkind Corp | |
| CN101389348A (zh) | 2006-02-22 | 2009-03-18 | 曼金德公司 | 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法 |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| US9358352B2 (en) | 2008-06-13 | 2016-06-07 | Mannkind Corporation | Dry powder drug delivery system and methods |
| CN109568740B (zh) | 2008-06-13 | 2022-05-27 | 曼金德公司 | 干粉吸入器和用于药物输送的系统 |
| BR122020002400B1 (pt) | 2008-06-20 | 2021-12-07 | Mannkind Corporation | Sistema de detecção de inalação de pó seco e sistema de monitoramento acoplável para um inalador de pó seco |
| TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| JP5918539B2 (ja) * | 2009-01-08 | 2016-05-18 | マンカインド コーポレイション | Ｇｌｐ−１を用いる高血糖症の治療方法 |
| KR101733816B1 (ko) * | 2009-03-04 | 2017-05-08 | 맨카인드 코포레이션 | 개선된 건조 분말 약물 전달 시스템 |
| PL2405963T3 (pl) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Urządzenie, układ i sposób pomiaru oporu inhalatora |
| CA2764505C (en) | 2009-06-12 | 2018-09-25 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
| JP6133270B2 (ja) | 2011-04-01 | 2017-05-24 | マンカインド コーポレイション | 薬剤カートリッジのためのブリスター包装 |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| HK1201475A1 (en) | 2011-10-24 | 2015-09-04 | Mannkind Corporation | Methods and compositions for treating pain |
| CA2878457C (en) | 2012-07-12 | 2021-01-19 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| US9171343B1 (en) | 2012-09-11 | 2015-10-27 | Aseko, Inc. | Means and method for improved glycemic control for diabetic patients |
| US9897565B1 (en) | 2012-09-11 | 2018-02-20 | Aseko, Inc. | System and method for optimizing insulin dosages for diabetic subjects |
| EP2911690A1 (en) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalable influenza vaccine compositions and methods |
| MX392016B (es) | 2013-03-15 | 2025-03-21 | Mannkind Corp | Composiciones de dicetopiperazina microcristalina y métodos. |
| EP3021834A1 (en) | 2013-07-18 | 2016-05-25 | MannKind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
| JP2016530930A (ja) | 2013-08-05 | 2016-10-06 | マンカインド コーポレイション | 通気装置及び方法 |
| US9898585B2 (en) | 2014-01-31 | 2018-02-20 | Aseko, Inc. | Method and system for insulin management |
| US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
| AU2015339576B2 (en) | 2014-10-27 | 2020-02-06 | Glytec, Llc | Subcutaneous outpatient management |
| JP7109155B2 (ja) | 2015-06-04 | 2022-07-29 | キッコーマン株式会社 | フラビン結合型グルコースデヒドロゲナーゼを用いたグルコースの測定方法 |
| WO2017031440A1 (en) | 2015-08-20 | 2017-02-23 | Aseko, Inc. | Diabetes management therapy advisor |
| CN110187123B (zh) * | 2019-05-06 | 2022-07-22 | 天津医科大学总医院 | 一种糖尿病早期诊断生物标志物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ500075A (en) * | 1997-04-02 | 2001-03-30 | Purdue Research Foundation | Method for the oral delivery of a protein encapsulated within a hydrogel matrix |
| CA2377204C (en) * | 1999-06-29 | 2015-01-20 | Pharmaceutical Discovery Corporation | Purification and stabilization of peptide and protein pharmaceutical agents |
| GB0217382D0 (en) * | 2002-07-26 | 2002-09-04 | Pfizer Ltd | Process for making orally consumable dosage forms |
| AU2004220544B2 (en) * | 2003-03-06 | 2010-06-17 | Emisphere Technologies, Inc. | Oral insulin therapies and protocol |
| ES2584867T3 (es) * | 2004-01-12 | 2016-09-29 | Mannkind Corporation | Un método que reduce los niveles séricos de proinsulina en diabéticos de tipo 2 |
-
2006
- 2006-08-01 CN CNA2006800283625A patent/CN101232899A/zh active Pending
- 2006-08-01 CA CA002617226A patent/CA2617226A1/en not_active Abandoned
- 2006-08-01 JP JP2008525132A patent/JP2009503093A/ja active Pending
- 2006-08-01 BR BRPI0614489-6A patent/BRPI0614489A2/pt not_active Application Discontinuation
- 2006-08-01 WO PCT/US2006/030014 patent/WO2007016600A2/en not_active Ceased
- 2006-08-01 DK DK06789148.1T patent/DK1915171T3/da active
- 2006-08-01 AU AU2006275424A patent/AU2006275424B2/en not_active Ceased
- 2006-08-01 MX MX2008001643A patent/MX2008001643A/es not_active Application Discontinuation
- 2006-08-01 ES ES06789148.1T patent/ES2439455T3/es active Active
- 2006-08-01 EP EP06789148.1A patent/EP1915171B1/en not_active Not-in-force
-
2015
- 2015-01-08 JP JP2015002059A patent/JP2015091854A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009503093A5 (cg-RX-API-DMAC7.html) | ||
| US20240181019A1 (en) | Use of ultrarapid acting insulin | |
| AU2006275424B2 (en) | Method of preserving the function of insulin-producing cells | |
| US20250064898A1 (en) | Insulin glargine/lixisenatide fixed ratio formulation | |
| Russell‐Jones et al. | Recent advances in incretin‐based therapies | |
| ES2930673T3 (es) | Uso de insulina de acción ultrarrápida | |
| JP5788374B2 (ja) | 糖尿病治療における優れた血糖コントロール | |
| CN101027082A (zh) | 降低2型糖尿病患者血清胰岛素原水平的方法 | |
| JP2007517892A5 (cg-RX-API-DMAC7.html) | ||
| JP2020510628A5 (cg-RX-API-DMAC7.html) | ||
| US20240342251A1 (en) | Method of treating hypoglycemia events in diabetes treatment | |
| Razavi-Nematollahi et al. | Adverse effects of glycemia-lowering medications in type 2 diabetes | |
| JP2020502151A5 (cg-RX-API-DMAC7.html) | ||
| AU2013204281C1 (en) | Use of ultrarapid acting insulin | |
| CN116018156A (zh) | 使用人类胰淀素类似物多肽对1型糖尿病患者提供卓越的血糖控制 | |
| HK1242994B (en) | Use of ultrarapid acting insulin |